Aptevo Therapeutics APVO reported its Q4 earnings results on Thursday, March 24, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Aptevo Therapeutics missed estimated earnings by 3.1%, reporting an EPS of $-1.33 versus an estimate of $-1.29.
Revenue was up $1.29 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 8.71% drop in the share price the next day.
Here's a look at Aptevo Therapeutics's past performance:
|Quarter||Q3 2021||Q2 2021||Q1 2021||Q4 2020|
Listen to the earnings announcement yourself by clicking here.
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.